AAAAAA

   
Results: 1-10 |
Results: 10
The use and misuse of neck dissection for head and neck cancer
Authors: Robbins, KT Atkinson, JLD Byers, RM Cohen, JI Lavertu, P Pellitteri, P
Citation: Kt. Robbins et al., The use and misuse of neck dissection for head and neck cancer, J AM COLL S, 193(1), 2001, pp. 91-102
P53 and Ki-67 as outcome predictors for advanced squamous cell cancers of the head and neck treated with chemoradiotherapy
Authors: Lavertu, P Adelstein, DJ Myles, J Secic, M
Citation: P. Lavertu et al., P53 and Ki-67 as outcome predictors for advanced squamous cell cancers of the head and neck treated with chemoradiotherapy, LARYNGOSCOP, 111(11), 2001, pp. 1878-1892
Hypothyroidism - A frequent event after radiotherapy and after radiotherapy with chemotherapy for patients with head and neck carcinoma
Authors: Mercado, G Adelstein, DJ Saxton, JP Secic, M Larto, MA Lavertu, P
Citation: G. Mercado et al., Hypothyroidism - A frequent event after radiotherapy and after radiotherapy with chemotherapy for patients with head and neck carcinoma, CANCER, 92(11), 2001, pp. 2892-2897
Enteral nutrition during the treatment of head and neck carcinoma - Is a percutaneous endoscopic gastrostomy tube preferable to a nasogastric tube?
Authors: Mekhail, TM Adelstein, DJ Rybicki, LA Larto, MA Saxton, JP Lavertu, P
Citation: Tm. Mekhail et al., Enteral nutrition during the treatment of head and neck carcinoma - Is a percutaneous endoscopic gastrostomy tube preferable to a nasogastric tube?, CANCER, 91(9), 2001, pp. 1785-1790
Systemic adoptive T-cell immunotherapy in recurrent and metastatic carcinoma of the head and neck - A phase 1 study
Authors: To, WC Wood, BG Krauss, JC Strome, M Esclamado, RM Lavertu, P Dasko, D Kim, JA Plautz, GE Leff, BE Smith, V Sandstrom-Wakeling, K Shu, SY
Citation: Wc. To et al., Systemic adoptive T-cell immunotherapy in recurrent and metastatic carcinoma of the head and neck - A phase 1 study, ARCH OTOLAR, 126(10), 2000, pp. 1225-1231
Mature results of a phase III randomized trial comparing concurrent chemoradiotherapy with radiation therapy alone in patients with stage III and IV squamous cell carcinoma of the head and neck
Authors: Adelstein, DJ Lavertu, P Saxton, JP Secic, M Wood, BG Wanamaker, JR Eliachar, I Strome, M Larto, MA
Citation: Dj. Adelstein et al., Mature results of a phase III randomized trial comparing concurrent chemoradiotherapy with radiation therapy alone in patients with stage III and IV squamous cell carcinoma of the head and neck, CANCER, 88(4), 2000, pp. 876-883
Aggressive concurrent chemoradiotherapy for squamous cell head and neck cancer - An 8-year single-institution experience
Authors: Lavertu, P Adelstein, DJ Saxton, JP Secic, M Eliachar, I Strome, M Larto, MA Wood, BG
Citation: P. Lavertu et al., Aggressive concurrent chemoradiotherapy for squamous cell head and neck cancer - An 8-year single-institution experience, ARCH OTOLAR, 125(2), 1999, pp. 142-148
Cisplatin ototoxicity - The importance of baseline audiometry
Authors: Nagy, JL Adelstein, DJ Newman, CW Rybicki, LA Rice, TW Lavertu, P
Citation: Jl. Nagy et al., Cisplatin ototoxicity - The importance of baseline audiometry, AM J CL ONC, 22(3), 1999, pp. 305-308
Impact of steroids on recovery after uvulopalatopharyngoplasty
Authors: Williams, PM Strome, M Eliachar, I Lavertu, P Wood, BG Vito, KJ
Citation: Pm. Williams et al., Impact of steroids on recovery after uvulopalatopharyngoplasty, LARYNGOSCOP, 109(12), 1999, pp. 1941-1946
Plasmacytomas of the head and neck
Authors: Miller, FR Lavertu, P Wanamaker, JR Bonafede, J Wood, BG
Citation: Fr. Miller et al., Plasmacytomas of the head and neck, OTO H N SUR, 119(6), 1998, pp. 614-618
Risultati: 1-10 |